Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 11, 2016 11:40 AM ET

Pharmaceuticals

Company Overview of Prolong Pharmaceuticals, LLC

Company Overview

Prolong Pharmaceuticals, LLC, a biopharmaceutical company, develops products for the treatment of anemia resulting from oxygen deficiency and hemolysis. It offers SANGUINATE, an investigational bio-pharmaceutical product that facilitates the transfer of oxygen to oxygen-deprived cells and tissues and down-regulates the inflammatory response in blood samples of sickle cell disease (SCD) patients. The company’s products also include ANF-Rho to create a novel molecule with a unique mechanism of action; EPEG, a long-acting 3rd generation PEGylated EPO biologic for the treatment of anemia; and PP-403, a novel cytokine with applications in cancer; and hematology products. Prolong Pharmaceuticals, ...

1 Cragwood Road

Suite 203

South Plainfield, NJ 07080

United States

Founded in 2002

Phone:

908-444-4660

Fax:

908-444-4661

Key Executives for Prolong Pharmaceuticals, LLC

Founder, Chief Executive Officer, Chief Scientific Officer and Director
President
Age: 54
Vice President of Information Services
Director of Development
Vice President of Quality
Compensation as of Fiscal Year 2015.

Prolong Pharmaceuticals, LLC Key Developments

Prolong Pharmaceuticals, LLC Presents at Boston Biotech Conferences 2015, Nov-12-2015 01:30 PM

Prolong Pharmaceuticals, LLC Presents at Boston Biotech Conferences 2015, Nov-12-2015 01:30 PM. Venue: Apella, 450 East 29th Street, NY 10016, New York, United States. Speakers: Glenn Kazo, President.

Prolong Pharmaceuticals, Inc. Presents at The 2nd Annual Sachs Cancer Bio Partnering & Investment Forum, Mar-19-2014 04:15 PM

Prolong Pharmaceuticals, Inc. Presents at The 2nd Annual Sachs Cancer Bio Partnering & Investment Forum, Mar-19-2014 04:15 PM. Venue: New York Academy of Sciences, New York, United States.

Similar Private Companies By Industry

Company Name Region
SynDevRx, Inc. United States
Alfama, Inc. United States
Fuse Science, Inc. United States
Oncology Research Therapeutics United States
Life Plus International United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Prolong Pharmaceuticals, LLC, please visit www.prolongpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.